Clinical ink
Winston-Salem, US · Delaware corporation · 4 known investors
Digital data collection and clinical trial technology platform offering Direct Data Capture, eCOA, eConsent, and digital biomarkers.
Founders & leadership
AG
Ansbert GadickeDirector
MK
Matt KingDirector
JS
Joe SchmidtExecutive Officer
BG
Brad GeesamanDirector
RK
Robert KniejskiDirector
TF
Todd FoleyDirector
MJ
Morana Jovan-EmbiricosDirector
PR
Philip RS Waugh, Jr.Director
DE
Douglas E. Pierce, Jr.Executive Officer, Director, Promoter
ES
Edward S. SeguineExecutive Officer, Director, Promoter
Investors · 4
Reported raises · per SEC filings
Form D private placements▶$5.3MraisedMay 2018 · 5 investors · OtherRule 506(b)
▶$5.3MraisedMay 2018 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Matthew KingDirector
- Edward S. Seguine, Jr.Executive Officer, Director
- Richard MalcolmDirector
- Roger LaVern DavenportDirector
- Michael SorensenDirector
- Amount sold
- $5.3M
- Minimum investment
- $2.7K
- First sale
- May 2018
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$1.7MraisedDec 2017 · 9 investors · OtherRule 506(b)
▶$1.7MraisedDec 2017 · 9 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Tony RosenbergDirector
- Phil WaughDirector
- Todd FoleyDirector
- Richard MalcolmDirector
- Scott MiltenbergerExecutive Officer
- Edward S. Seguine, Jr.Executive Officer, Director
- Matt KingDirector
- Offering amount
- $2.5M
- Amount sold
- $1.7M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$9.9MraisedApr 2015 · 21 investors · OtherRule 506(b)
▶$9.9MraisedApr 2015 · 21 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Ansbert GadickeDirector
- Matt KingDirector
- Joe SchmidtExecutive Officer
- Brad GeesamanDirector
- Robert KniejskiDirector
- Todd FoleyDirector
- Morana Jovan-EmbiricosDirector
- Philip RS Waugh, Jr.Director
- Douglas E. Pierce, Jr.Executive Officer, Director, Promoter
- Edward S. SeguineExecutive Officer, Director, Promoter
- Offering amount
- $9.9M
- Amount sold
- $9.9M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.